KKR to acquire disease specialist Immedica Pharma

KKR to acquire disease specialist Immedica Pharma

Investment funds managed by global private investment firm KKR will acquire Immedica Pharma, a Swedish pharmaceutical company focused on the commercialisation of medicines for rare diseases and specialty care products. Nordic healthcare investment firm Impilo, the...